A White Paper on the Efficacy of Cannabinoids As Topical Treatments for Acne
Acne vulgaris is a highly prevalent inflammatory skin condition that affects over 9% of the world’s population. Most acne presents as non-inflammatory comedones and inflammatory lesions, and treatment is complicated due to the diverse etiology and multi-faceted pathogenesis of this condition.
Current in-vitro scientific evidence suggests that non-cytotoxic doses of cannabinoids including THCV, CBD, CBG and CBGV have an effect on sebum production, gram-positive bacteria and inflammatory immune response for treating a variety of dermatological conditions. These cannabinoids present an opportunity to provide highly effective topical anti-acne treatments based on two key discoveries:
- Cannabinoids demonstrate they can normalize sebum production and may serve as antimicrobial treatments capable of combating gram-positive bacteria that form in the pore.
- The anti-inflammatory qualities of cannabinoids can serve as treatments for other dermatological conditions including xerosis, eczema, psoriasis and the effects of aging.
LAVVAN’s advanced cellular agriculture platform offers a way to produce high-quality, pure cannabinoid ingredients at exact dosages to keep pace with the anticipated increase in research around anti-acne use cases and demand by the skin care markets.
Download our white paper for full details on current studies investigating the potential of topical cannabinoid applications as anti-acne treatments.